INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
06/07/2026
Back to search
Official data from USPTO
360 BIOLABS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
06/08/2026
Trademark type
Word
Nice classes
42
Filing date
12/20/2018
Registration date
08/27/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/07/2025
Last transaction
06/08/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
MELBOURNE VIC, AU
Examiner
LATTUCA, FRANK J
Current location
Historical data usage
Holders and representatives
Holders
360 BIOLABS PTY LTD
360 BIOLABS PTY LTD
Representatives
Ashley N. Klein Bradley Arant Boult Cummings LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and technological services and research and design relating thereto for the development of therapeuticmedicinalpharmaceuticalvaccinationimmunotherapy and diagnostic technology and products; design and development servicesdesign and development of new therapeuticmedicinalpharmaceuticalvaccinationimmunotherapy and diagnostic technology and products; laboratory analysis and research in the field of therapeuticmedicalpharmaceuticalvaccinationimmunothrapy * immunotherapy * and diagnostic technology and products; quality assurance services in the field of the design and development of therapeuticmedicalpharmaceuticalvaccinationimmunotherapy and diagnostic technology and products; testinganalysis and evaluation of the goods of others to determine conformity with certification standards; quality control for others; laboratory testing services in the field of therapeuticmedicalpharmaceuticalvaccinationimmunotherapy and diagnostic thechnoloty * technology * and products; conducting clinical trials for others; biological research; development services in the field of therapeuticmedicinalpharmaceuticalvaccinationimmunotherapy and diagnostic technology and products; advisory and consultancy services in the field of the designdevelopment and research of therapeuticmedicinalpharmaceuticalvaccinationimmunotherapy and diagnostic technology and products
Publications
History of USPTO decisions and trademark events.
34 publications found
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
10/07/2025
71AG
REGISTERED-SEC.71 ACCEPTED
10/07/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/06/2025
ES71
TEAS SECTION 71 RECEIVED
06/30/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/27/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/02/2021
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
08/13/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
07/05/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/10/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/21/2019
FIMP
FINAL DISPOSITION PROCESSED
12/21/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/27/2019
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
11/05/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/04/2019
ES7R
TEAS SECTION 7 REQUEST RECEIVED
10/04/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
08/27/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/11/2019
PUBO
PUBLISHED FOR OPPOSITION
06/11/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/22/2019
ALIE
ASSIGNED TO LIE
05/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/22/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/16/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/16/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/16/2019
RFNT
REFUSAL PROCESSED BY IB
04/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/28/2019
RFRR
REFUSAL PROCESSED BY MPU
03/27/2019
MAFR
APPLICATION FILING RECEIPT MAILED
03/21/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/18/2019
CNRT
NON-FINAL ACTION WRITTEN
03/17/2019
DOCK
ASSIGNED TO EXAMINER
03/17/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/17/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/14/2019
Continuous trademark protection
Get notified about every new filing that threatens 360 BIOLABS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.